INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,199 | +207.9% | 2,384 | +83.7% | 0.00% | +100.0% |
| Q2 2023 | $14,356 | -17.6% | 1,298 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $17,432 | -15.6% | 1,298 | -22.3% | 0.00% | 0.0% |
| Q4 2022 | $20,658 | -11.3% | 1,670 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $23,297 | +1.0% | 1,670 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $23,063 | -15.1% | 1,670 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $27,171 | -75.9% | 1,670 | -75.9% | 0.00% | -50.0% |
| Q4 2021 | $112,906 | -3.9% | 6,931 | -12.4% | 0.00% | 0.0% |
| Q3 2021 | $117,538 | -25.6% | 7,915 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $158,063 | -13.5% | 7,915 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $182,678 | -6.6% | 7,915 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $195,501 | -40.4% | 7,915 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $328,156 | -13.5% | 7,915 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $379,208 | -19.5% | 7,915 | +5.8% | 0.01% | -30.0% |
| Q1 2020 | $471,067 | -52.1% | 7,482 | -5.6% | 0.01% | -37.5% |
| Q4 2019 | $982,686 | +82.5% | 7,930 | -2.3% | 0.02% | +77.8% |
| Q3 2019 | $538,379 | -8.2% | 8,113 | +10.1% | 0.01% | -10.0% |
| Q2 2019 | $586,351 | -26.9% | 7,369 | +2.8% | 0.01% | -33.3% |
| Q1 2019 | $802,036 | +11.0% | 7,170 | 0.0% | 0.02% | +7.1% |
| Q4 2018 | $722,664 | -20.2% | 7,170 | 0.0% | 0.01% | -12.5% |
| Q3 2018 | $906,001 | -99.8% | 7,170 | 0.0% | 0.02% | +60.0% |
| Q2 2018 | $601,635,000 | +632.0% | 7,170 | +436.7% | 0.01% | +900.0% |
| Q1 2018 | $82,191,000 | +105273.1% | 1,336 | +0.1% | 0.00% | 0.0% |
| Q4 2017 | $78,000 | 0.0% | 1,335 | -1.1% | 0.00% | – |
| Q3 2017 | $78,000 | -49.7% | 1,350 | +5.4% | 0.00% | -100.0% |
| Q2 2017 | $155,000 | +22.0% | 1,281 | +13.8% | 0.00% | 0.0% |
| Q1 2017 | $127,000 | +4.1% | 1,126 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $122,000 | -37.1% | 1,126 | -4.4% | 0.00% | 0.0% |
| Q3 2016 | $194,000 | +10.2% | 1,178 | -4.5% | 0.00% | 0.0% |
| Q2 2016 | $176,000 | +14.3% | 1,234 | +3.2% | 0.00% | 0.0% |
| Q1 2016 | $154,000 | -14.0% | 1,196 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $179,000 | -7.3% | 1,196 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $193,000 | -31.3% | 1,164 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $281,000 | +6.0% | 1,164 | +23.7% | 0.00% | 0.0% |
| Q1 2015 | $265,000 | +93.4% | 941 | +7.1% | 0.00% | +100.0% |
| Q4 2014 | $137,000 | -32.5% | 879 | +2.7% | 0.00% | 0.0% |
| Q3 2014 | $203,000 | -0.5% | 856 | -0.7% | 0.00% | 0.0% |
| Q2 2014 | $204,000 | -89.0% | 862 | -84.7% | 0.00% | -92.3% |
| Q1 2014 | $1,856,000 | +380.8% | 5,628 | -0.4% | 0.01% | +333.3% |
| Q4 2013 | $386,000 | -1.0% | 5,652 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $390,000 | +54.2% | 5,652 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $253,000 | – | 5,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |